The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report.
Here are 12 key market players:
1. Arthrex
2. Arteriocyte Medical Systems
3. DePuy Synthes
4. Biomet
5. Cesca Therapeutics
6. Dr. PRP America
7. EmCyte Corp.
8. AdiStem
9. Exactech
10. Nuo Therapeutics
11. Regen Lab
12. Harvest Technologies Corp.